SHARE
COPY LINK

HEALTH

Europe warned to prepare for mpox as Pakistan reports first case

Health authorities warned Friday that Europe must be ready for more cases of a deadly strain of mpox that has killed hundreds of people in the Democratic Republic of Congo.

Europe warned to prepare for mpox as Pakistan reports first case
A health worker takes a sample at the Mpox treatment centre of the Nyiragongo general referral hospital, north of the town of Goma in the Democratic Republic of Congo. Photo: GUERCHOM NDEBO/AFP.

The World Health Organisation urged pharmaceutical firms to ramp up vaccine production and China said it would screen travellers for the disease after the first cases of the more deadly strain to be recorded outside Africa were announced in Sweden and Pakistan.

France’s Prime Minister Gabriel Attal said his country was on the “highest alert” and would implement “new recommendations” for travellers to risk areas.

Mpox is caused by a virus transmitted to humans by animals but can also spread human-to-human through close physical contact.

It causes fever, muscular aches and large boil-like skin lesions.

The WHO on Wednesday declared the rapid spread of the new Clade 1b strain an international public health emergency — the agency’s highest alert.

This follows the spread of the more deadly mpox from Democratic Republic of Congo (DRC) to other African countries.

READ ALSO: Sweden reports first case of deadly mpox strain outside Africa

“We do need the manufacturers to really scale up so that we’ve got access to many, many more vaccines,” WHO spokeswoman Margaret Harris told reporters.

The WHO is asking countries with vaccine stockpiles to donate them to countries with outbreaks.

Harris said mpox was “particularly dangerous for those with a weak immune system, so people who maybe have HIV or are malnourished”, and was also dangerous for small children.

The United States has said it will donate 50,000 doses of an mpox vaccine to DRC and Attal said France would also send vaccines to risk countries.

Danish drugmaker Bavarian Nordic said Thursday it would be ready to make up to 10 million doses of its mpox vaccine by 2025 but that it needed contracts to start production.

The Stockholm-based European Centre for Disease Prevention and Control (ECDC) said the overall risk in Europe was “low”. But it warned that “effective surveillance, laboratory testing, epidemiological investigation and contact tracing capacities will be vital to detecting cases.”

“Due to the close links between Europe and Africa, we must be prepared for more imported clade I cases,” ECDC director Pamela Rendi-Wagner said in a statement.

Hundreds killed in DRC

The virus has swept across DRC, killing 548 people so far this year, the government said Thursday.

Nigeria has recorded 39 mpox cases this year, but no deaths, according to its health authorities. Previously unaffected countries such as Burundi, Kenya, Rwanda and Uganda have reported outbreaks, according to the Africa Centres for Disease Control and Prevention.

Sweden’s Public Health Agency announced Thursday it had registered a case of Clade 1b.

The patient was infected during a visit to “the part of Africa where there is a major outbreak of mpox Clade 1”, epidemiologist Magnus Gisslen said in a statement.

The mpox strain in the Pakistan case was not immediately known, the country’s health ministry said in a statement.

It said the patient, a 34-year-old man, had “come from a Gulf country”.

China announced it would begin screening people and goods entering the country for mpox over the next six months.

People arriving from countries where outbreaks have occurred, who have been in contact with mpox cases or display symptoms should “declare to customs when entering the country”, China’s customs administration said.

Vehicles, containers and items from areas with mpox cases should be sanitised, it added in a statement.

Vaccination drive

Mpox has two subtypes: the more virulent and deadlier Clade 1, endemic in the Congo Basin in central Africa; and Clade 2, endemic in West Africa.

A worldwide outbreak beginning in 2022 involving the Clade 2b subclade caused some 140 deaths out of about 90,000 cases, mostly affecting gay and bisexual men.

France reported 107 cases of the milder mpox variant between January 1 and June 30 this year.

The WHO’s European regional office in Copenhagen said the Sweden case was “a clear reflection of the interconnectedness of our world”.

But it added: “Travel restrictions and border closures don’t work and should be avoided.”

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

HEALTH

French authorities launch giant health survey of residents in Paris and south-west France

From takeways to tap water, chemicals to exercise, French health authorities are launching a giant survey on the health of the population - selecting people living in Paris and south-west France to answer a detailed set of health questions.

French authorities launch giant health survey of residents in Paris and south-west France

If you live in Paris or the south-west France region of Nouvelle-Aquitaine you may soon be receiving in the post a letter inviting you to take part in a health survey.

The French public health body Santé Publique France has announced the launch of a giant survey it has named Albane which aims to “document the state of health of the population living in France, their eating habits and physical activity, as well as their exposure to various chemical substances”.

The study will involve 400 randomly-selected people (200 adults and 200 children) who will be invited to take part in a detailed survey intended to give a snapshot of the nation’s health. 

Among the topics covered will be whether people drink tap water or mineral water, whether they buy organic fruit and vegetables or not, how often they cook, the type of chemicals they may be exposed to at home or work and whether they walk regularly.

The survey will begin in Paris and Nouvelle-Aquitaine, and then be extended to 3,000 people in France’s other regions from March 2025.

Anyone selected to take part will receive a letter through the mail from Santé Publique France and the Agence nationale de sécurité sanitaire (Anses) referencing the Albane enquiry and inviting them to take part.

What does it involve?

Being a survey participant comes in two parts – first is the detailed questionnaire looking at all aspects of health from diet and exercise to daily life.

Survey participants will also be asked to attend a medical laboratory where they will receive a medical check-up (height, weight, muscle tone etc) as well as giving blood and urine samples that will be analysed for exposure to chemicals.

Some participants may be required to wear an activity tracker such as a Fitbit in order to monitor their health and activity over the course of several days.

Can I refuse?

Yes, the first part of the process involves asking for the consent of those involved, so you have the option to say no.

It is not possible to volunteer to be a participant, as those invited are selected to provide a representative sample of the population.

Why are they doing this?

Éric Vial, Director of Risk Assessment at Anses and one of the study leaders, told Le Parisien: “The role of diet in increasing or preventing certain diseases, such as cancer, obesity and cardiovascular disease, has now been established.

“But in order to better prevent these diseases and improve the population’s state of health, it is essential to have a good understanding of our diet and nutritional status.

“Our aim is to assess the nutritional, microbiological and chemical risks to which people are exposed as a result of their eating habits. The other parts of the survey involve gathering information about the individual’s environment, at home and at work, and their state of health.”

Find more details on Albane here.

SHOW COMMENTS